← Back to Search

Behavioral Intervention for Chronic Migraine (RLB Trial)

N/A

Recruiting

Led By Yohannes Woldeamanuel, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

aged 18 years and older

Aged 18 years and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

RLB Trial Summary

This trial will test a new protocol to manage chronic migraine and investigate biomolecules involved in chronic migraine patients who respond to the protocol.

Who is the study for?

This trial is for adults who have been experiencing chronic migraines for at least one year. It's not suitable for individuals with other types of headaches, those under 18, or pregnant women.Check my eligibility

What is being tested?

The study is testing a lifestyle behavior protocol designed to manage chronic migraines and will compare it against a sham (placebo) protocol. The trial also aims to identify specific biomolecules related to the condition.See study design

What are the potential side effects?

Since this is a behavioral intervention focusing on lifestyle changes rather than medication, significant side effects are not expected. However, participants may experience discomfort or stress from changing their habits.

RLB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am 18 years old or older.

Select...

I have had chronic migraines for at least 1 year.

Select...

I have had chronic migraines for at least 1 year.

RLB Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Feasibility

Secondary outcome measures

Mean change from baseline monthly migraine frequency

Migraine severity

Other outcome measures

Headache self-efficacy

Levels of candidate biomarkers

RLB Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Virtual Therapy GroupActive Control1 Intervention

Group II: Attention Placebo GroupPlacebo Group1 Intervention

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,285 Total Patients Enrolled

3 Trials studying Migraine

89 Patients Enrolled for Migraine

National Institute of Neurological Disorders and Stroke (NINDS)NIH

1,341 Previous Clinical Trials

649,319 Total Patients Enrolled

7 Trials studying Migraine

1,172 Patients Enrolled for Migraine

Yohannes Woldeamanuel, MDPrincipal InvestigatorStanford University

Media Library

Lifestyle Behavior Protocol Clinical Trial Eligibility Overview. Trial Name: NCT05415020 — N/A

Migraine Research Study Groups: Virtual Therapy Group, Attention Placebo Group

Migraine Clinical Trial 2023: Lifestyle Behavior Protocol Highlights & Side Effects. Trial Name: NCT05415020 — N/A

Lifestyle Behavior Protocol 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415020 — N/A

Migraine Patient Testimony for trial: Trial Name: NCT05415020 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals still able to participate in this experiment?

"This clinical study is presently searching for participants, as indicated on clinicaltrials.gov. It was initially posted in late June of 2022 and has been revised most recently in September of the same year."

Answered by AI

What is the sample size for this research endeavor?

"Affirmative. Data found on clinicaltrials.gov reveals that, since it was initially posted on June 29th 2022, this medical research is actively recruiting patients. 70 individuals are being sought out from one solitary location to participate in the study."

Answered by AI